Roche Licenses Rights to Develop Assay, Companion Dx for EGFR Mutations

In separate agreements, Roche has obtained a worldwide sub-license from Genzyme to develop the EGFR assay, and will collaborate with OSI Pharmaceuticals to develop the companion diagnostic.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.